Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

408 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion.
Franco R, Zappavigna S, Gigantino V, Luce A, Cantile M, Cerrone M, Facchini G, Perdonà S, Pignata S, Di Lorenzo G, Chieffi S, Vitale G, De Sio M, Sgambato A, Botti G, Yousif AM, Novellino E, Grieco P, Caraglia M. Franco R, et al. Among authors: facchini g. J Exp Clin Cancer Res. 2014 Jun 3;33(1):48. doi: 10.1186/1756-9966-33-48. J Exp Clin Cancer Res. 2014. PMID: 24893613 Free PMC article.
Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
Ottaiano A, Franco R, Aiello Talamanca A, Liguori G, Tatangelo F, Delrio P, Nasti G, Barletta E, Facchini G, Daniele B, Di Blasi A, Napolitano M, Ieranò C, Calemma R, Leonardi E, Albino V, De Angelis V, Falanga M, Boccia V, Capuozzo M, Parisi V, Botti G, Castello G, Vincenzo Iaffaioli R, Scala S. Ottaiano A, et al. Among authors: facchini g. Clin Cancer Res. 2006 May 1;12(9):2795-803. doi: 10.1158/1078-0432.CCR-05-2142. Clin Cancer Res. 2006. PMID: 16675573
New treatment approaches in renal cell carcinoma.
Facchini G, Perri F, Caraglia M, Pisano C, Striano S, Marra L, Fiore F, Aprea P, Pignata S, Iaffaioli RV. Facchini G, et al. Anticancer Drugs. 2009 Nov;20(10):893-900. doi: 10.1097/CAD.0b013e32833123d4. Anticancer Drugs. 2009. PMID: 19752718 Review.
Treatment of recurrent epithelial ovarian cancer.
Pisano C, Bruni GS, Facchini G, Marchetti C, Pignata S. Pisano C, et al. Among authors: facchini g. Ther Clin Risk Manag. 2009 Aug;5(4):421-6. doi: 10.2147/tcrm.s4317. Epub 2009 Jun 22. Ther Clin Risk Manag. 2009. PMID: 19753136 Free PMC article.
Metronomic administration of zoledronic acid and taxotere combination in castration resistant prostate cancer patients: phase I ZANTE trial.
Facchini G, Caraglia M, Morabito A, Marra M, Piccirillo MC, Bochicchio AM, Striano S, Marra L, Nasti G, Ferrari E, Leopardo D, Vitale G, Gentilini D, Tortoriello A, Catalano A, Budillon A, Perrone F, Iaffaioli RV. Facchini G, et al. Cancer Biol Ther. 2010 Sep 15;10(6):543-8. doi: 10.4161/cbt.10.6.12611. Epub 2010 Sep 8. Cancer Biol Ther. 2010. PMID: 20657175 Clinical Trial.
Chemotherapy in epithelial ovarian cancer.
Pignata S, Cannella L, Leopardo D, Pisano C, Bruni GS, Facchini G. Pignata S, et al. Among authors: facchini g. Cancer Lett. 2011 Apr 28;303(2):73-83. doi: 10.1016/j.canlet.2011.01.026. Epub 2011 Feb 24. Cancer Lett. 2011. PMID: 21353386 Review.
408 results